Development of a combination chemotherapy program for adult acute leukemia: CAM and CAM-L.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D003520:Cyclophosphamide / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use*; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D012075:Remission, Spontaneous; D013997:Time Factors
D000970:Antineoplastic Agents; D003561:Cytarabine; D003520:Cyclophosphamide; D002955:Leucovorin; D008727:Methotrexate